Genomic Health, Inc. (GHDX) Tops Q4 EPS by 3c, Guides FY13

February 6, 2013 5:11 PM EST
Get Alerts GHDX Hot Sheet
Trade GHDX Now!
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q4 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $60.4 million versus the consensus estimate of $58.9 million.

Genomic Health, Inc. sees FY2013 revenue of $258-266 million, versus the consensus of $262.40 million.

For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment